BDBM560603 (S,E)-3-hydroxy-2-methyl-2-(3-(2-methyl-3-(2-methylbenzo[d]oxazol-6-yl)-styryl)-4-(trifluoromethyl)benzylamino)-3-hydroxy-2-methylpropanoic acid ::US11384048, Compound 43

SMILES CC1=NC2C=C(C=CC2O1)c1cccc(\C=C\c2cc(CN[C@@](C)(CO)C(O)=O)ccc2C(F)(F)F)c1C

InChI Key InChIKey=CDRPDYCYAFHBNE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 560603   

TargetProgrammed cell death 1 ligand/protein 1(Human)
Guangzhou Maxinovel Pharmaceuticals

US Patent
LigandPNGBDBM560603(US11384048, Compound 43 | (S,E)-3-hydroxy-2-methyl...)
Affinity DataIC50: 540nMAssay Description:Experimental Procedure1. The compound was formulated to 10 concentrations with a three-fold concentration gradient with 100% DMSO.2. The solution of ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2022
Entry Details
US Patent